PFM Health Sciences’s Akorn Inc AKRX Stock Holding History

PFM Health Sciences’s Portfolio AKRX Stock Details AKRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,817,174	Closed	-$43.8M	–	120
2017 Q1	$43.8M	Buy	+1,817,174	New	+$39.5M	1.1%	34

Other funds holding AKRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Twin Securities New York $206M AUM 77.79% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

PFM Health Sciences's AKRX Position: Q2 2017 in Review

PFM Health Sciences sold out of Akorn Inc (AKRX) in Q2 2017, closing a stake of 1,817,174 shares — an estimated $43.8M sold.

PFM Health Sciences first reported a position in AKRX in Q1 2017 and held it in 1 quarter. The position peaked at $43.8M in Q1 2017. 245 funds tracked by Wall St. Rank hold AKRX as of Q2 2017.

PFM Health Sciences reported no remaining Akorn Inc position as of Q2 2017 after selling out during the quarter.
PFM Health Sciences sold 1,817,174 Akorn Inc shares in Q2 2017, an estimated $43.8M.
PFM Health Sciences first reported a position in Akorn Inc in Q1 2017 and held it in 1 quarter.
PFM Health Sciences's Akorn Inc position peaked at $43.8M in Q1 2017.
245 funds tracked by Wall St. Rank held Akorn Inc as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.